フォロー
Alison Ritter
Alison Ritter
Drug Policy Modelling Program, UNSW Australia
確認したメール アドレス: unsw.edu.au
タイトル
引用先
引用先
A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs
A Ritter, J Cameron
Drug and alcohol review 25 (6), 611-624, 2006
4412006
The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS)
J Ross, M Teesson, S Darke, M Lynskey, R Ali, A Ritter, R Cooke
Drug and alcohol review 24 (5), 411-418, 2005
3072005
How do drug policy makers access research evidence?
A Ritter
International Journal of Drug Policy 20 (1), 70-75, 2009
2062009
Producing the ‘problem of drugs’: A cross national-comparison of ‘recovery’discourse in two Australian and British reports
K Lancaster, K Duke, A Ritter
International Journal of Drug Policy 26 (7), 617-625, 2015
1832015
One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS)
M Teesson, J Ross, S Darke, M Lynskey, R Ali, A Ritter, R Cooke
Drug and alcohol dependence 83 (2), 174-180, 2006
1812006
The reliability and internal validity of the Wisconsin Card Sorting Test
SC Bowden, KS Fowler, RC Bell, G Whelan, CC Clifford, AJ Ritter, ...
Neuropsychological Rehabilitation 8 (3), 243-254, 1998
1531998
Studying illicit drug markets: Disciplinary contributions
A Ritter
International Journal of Drug Policy 17 (6), 453-463, 2006
1412006
Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985–2010
K Lancaster, A Ritter
International Journal of Drug Policy 25 (1), 81-87, 2014
1392014
Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS)
S Darke, J Ross, M Teesson, R Ali, R Cooke, A Ritter, M Lynskey
Journal of substance abuse treatment 28 (3), 255-263, 2005
1282005
LAAM maintenance vs methadone maintenance for heroin dependence
NC Clark, N Lintzeris, A Gijsbers, G Whelan, A Dunlop, A Ritter, WW Ling, ...
Cochrane Database of Systematic Reviews 2010 (1), 1996
1281996
Serious adverse events in the Australian national evaluation of pharmacotherapies for opioid dependence (NEPOD)
E Digiusto, A Shakeshaft, A Ritter, S O'Brien, RP Mattick, ...
Addiction 99 (4), 450-460, 2004
1272004
Take-home naloxone for the emergency interim management of opioid overdose: the public health application of an emergency medicine
J Strang, R McDonald, G Campbell, L Degenhardt, S Nielsen, A Ritter, ...
Drugs 79, 1395-1418, 2019
1132019
Pill testing or drug checking in Australia: acceptability of service design features
MJ Barratt, R Bruno, N Ezard, A Ritter
Drug and alcohol review 37 (2), 226-236, 2018
1082018
A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting
AH Harris, E Gospodarevskaya, AJ Ritter
Pharmacoeconomics 23, 77-91, 2005
1072005
Global review of drug checking services operating in 2017
MJ Barratt, M Kowalski, LJ Maier, A Ritter
Drug policy modelling program bulletin 24, 1-23, 2018
1062018
The ethics of paying drug users who participate in research: A review and practical recommendations
CL Fry, W Hall, A Ritter, R Jenkinson
Journal of Empirical Research on Human Research Ethics 1 (4), 21-35, 2006
1042006
Paying research participants: a study of current practices in Australia
CL Fry, A Ritter, S Baldwin, KJ Bowen, P Gardiner, T Holt, R Jenkinson, ...
Journal of medical ethics 31 (9), 542-547, 2005
1012005
Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose
AJ Ritter
Australian & New Zealand Journal of Psychiatry 36 (2), 224-228, 2002
1002002
The influence of the therapeutic relationship in treatment for alcohol dependency
A Ritter, S Bowden, T Murray, P Ross, J Greeley, J Pead
Drug and alcohol review 21 (3), 261-268, 2002
972002
The deterrent effects of Australian street-level drug law enforcement on illicit drug offending at outdoor music festivals
CE Hughes, V Moxham-Hall, A Ritter, D Weatherburn, R MacCoun
International Journal of Drug Policy 41, 91-100, 2017
952017
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20